DrugPatentWatch Database Preview
Drugs in Development Information for CHS-828
Drug Development Status for CHS-828: Patents, clinical trial progress, indications
CHS-828 is an investigational drug.
There have been 14 clinical trials for CHS-828.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 21st 2017.
The most common disease conditions in clinical trials are Psoriasis, Arthritis, Rheumatoid, and Marijuana Abuse. The leading clinical trial sponsors are Coherus Biosciences, Inc., Baxalta US Inc., and Daiichi Sankyo Co., Ltd.
There are seventeen US patents protecting this investigational drug and two hundred and forty-nine international patents.
Summary for CHS-828
| US Patents | 17 |
| International Patents | 249 |
| US Patent Applications | 34 |
| WIPO Patent Applications | 17 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2017-05-21) |
| Vendors | 44 |
Recent Clinical Trials for CHS-828
| Title | Sponsor | Phase |
|---|---|---|
| Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo | Atrium Health | Phase 4 |
| Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC) | Queen's University | Phase 4 |
| Study to Assess the Pharmacokinetic and Pharmacodynamic Bioequivalence of CHS-1701 With Neulasta | Coherus Biosciences, Inc. | Phase 1 |
Clinical Trial Summary for CHS-828
Top disease conditions for CHS-828
Top clinical trial sponsors for CHS-828
US Patents for CHS-828
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| CHS-828 | See Pricing | Compounds and compositions for the inhibition of NAMPT | Forma TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA) | See Pricing |
| CHS-828 | See Pricing | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (Watertown, MA) Genentech, Inc. (South San Francisco, CA) | See Pricing |
| CHS-828 | See Pricing | N-cyano-N'-pyridylguanidines as serotonin antagonists | Leo Pharmaceutical Products Ltd. (Ballerup, DK) | See Pricing |
| CHS-828 | See Pricing | Cyanoguanidine prodrugs | Leo Pharmaceutical Products Ltd. A/S (Ballerup, DK) | See Pricing |
| CHS-828 | See Pricing | Cyanoguanidine prodrugs | LEO Pharma A/S (Ballerup, DK) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for CHS-828
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| CHS-828 | Argentina | 082885 | 2030-09-03 | See Pricing |
| CHS-828 | Australia | 2011295725 | 2030-09-03 | See Pricing |
| CHS-828 | Brazil | 112013004773 | 2030-09-03 | See Pricing |
| CHS-828 | Canada | 2810038 | 2030-09-03 | See Pricing |
| CHS-828 | Chile | 2013000588 | 2030-09-03 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
